Related Experiment Video
Updated: Jan 17, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Bidirectional association between chronic liver disease and chronic kidney disease: a longitudinal study based on
Yuan He1, Fan Zhang1, Zixuan Zhang1
1Department of Nephrology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Introduction And Objectives:
Chronic liver disease (CLD) and chronic kidney disease (CKD) are major public health concerns with significant morbidity and mortality worldwide. This study aimed to investigate the bidirectional association between CLD and CKD.
Patients And Methods:
We conducted two longitudinal studies using data from the China Health and Retirement Longitudinal Study (CHARLS) between 2011 and 2020. Participants without baseline CKD were analyzed for the risk of CKD associated with CLD, and participants without baseline CLD were assessed for the risk of CLD associated with CKD. Multivariate Cox proportional hazards models were used to estimate hazard ratios (HRs) with 95% confidence intervals (95% CIs).
Results:
Of 3651 participants without baseline CKD, 575 developed CKD over a median follow-up of 9 years. The incidence of CKD was significantly higher in those with baseline CLD (37.25 vs. 18.08 per 1000 population). Baseline CLD was independently associated with an elevated risk of incident CKD (adjusted HR=1.93; 95% CI: 1.37-2.72; P < 0.001). Conversely, of 5530 participants without baseline CLD, 474 developed CLD. Participants with CKD had a significantly higher incidence of CLD (13.56 vs. 8.89 per 1000 population). Baseline CKD was independently associated with an increased risk of incident CLD (adjusted HR=1.68; 95% CI: 1.31-2.16; P < 0.001). The bidirectional associations remained robust in sensitivity analyses, and the association persisted across different subgroups.
Conclusions:
This study provides evidence of a bidirectional relationship between CLD and CKD. These findings highlight the importance of integrated management strategies targeting both liver and kidney health.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Kidney Disease III: Interprofessional Care
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

